ArticleDiabetology & metabolic syndrome2018

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study).

Hiroki Nakajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.